HAI Solutions, founded in 2015, operates at the nexus of Biotechnology, Health Care, and Medical Devices. Their mission, encapsulated in their slogan, "Protect Patients. Infuse Life.", is to revolutionize clinical care, particularly in the realm of Intravenous Care and Vascular Access.
The company is advancing medical technologies to address intravenous contamination challenges, which are a significant financial burden, costing healthcare systems $15K to $30K per incident. By streamlining complex clinical workflows, HAI Solutions aims to enhance patient outcomes and reduce unnecessary costs across the healthcare spectrum.
Headquartered in the United States, the firm's innovative approach has attracted the attention of investors. Their most recent funding was a Seed Round investment on 01 January 2021, led by TiE SoCal Angels, suggesting a strong belief in their potential growth and disruptive capability in the healthcare industry.